Gossamer Bio Inc expected to post a loss of 15 cents a share - Earnings Preview

Gossamer Bio

06/11/2024 14:31

* Gossamer Bio Inc  GOSS.OQ   GOSS.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 7
(estimated) for the period ending September 30 2024
    * The San Diego California-based  company is expected to
report
revenue of $7.7 million, according to the mean estimate from 9
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Gossamer Bio Inc is for
a loss
of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is 7.00​, above​ its last closing price of $0.88. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  0.31        0.23       0.22      Missed  -3.9
 Jan. 1 2024   -0.19       -0.19      -0.19     Met     -0.5
 Dec. 31 2023  -0.19       -0.21      -0.21     Met     -1​
 Sep. 30 2023  -0.24       -0.26      -0.21     Beat    17.8
 ​​Jan.        -0.48       -0.49      -0.45     Beat    8
 1 0001                                                 
 Mar. 31 2023  -0.52       -0.53      -0.52     Beat    1.8​
 Jan. 1 0001   -0.62       -0.62      -0.59     Beat    5.3
 Sep. 30 2022  -0.66       -0.64      -0.65     Missed  -2.3
 This summary was machine generated November 6 at 14:30 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)